CytomX Therapeutics is a startup based in the United States, 2 tracked investors.
CytomX Therapeutics is a company founded in 2008 headquartered in the United States. Brouky records 2 investors associated with the company.
CytomX Therapeutics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer and immune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.